Hull York Medical School University of Hull University of York University of Liverpool Hull University Teaching Hospital NHS Trust King's College Hospital NHS Foundation Trust
BioDrive Logo

The BioDrive ANTIFUNGAL STEWARDSHIP TRIAL

NIHR HTA Grant Programme

Resources

Filters

Scientific Paper United Kingdom
CON: Serum biomarker monitoring should not replace primary antifungal chemoprophylaxis
Author: 
Country:  United Kingdom
CON: Serum biomarker monitoring should not replace primary antifungal chemoprophylaxis in patients with acute leukaemia receiving systemic anti-cancer therapy published in the Journal of of Antimicrobial Chemotherapy. Authors Alex Howard and William Hope (BioDriveAFS Trial Management Group Members)
Fungal diagnostics Stewardship Critically ill United Kingdom
Fungal Diagnostics in Critically Ill Patients
Author:  British Society for Antimicrobial Chemotherapy
Country:  United Kingdom
Open access on-line e-learning course
Scientific Paper Plain English Summary United Kingdom
Plain English Summary – Maertens et al. (2021), Posaconazole versus voriconazole for primary treatment of invasive aspergillosis
Author:  Thomas Taynton on behalf of BioDriveAFS team
Country:  United Kingdom
Plain English Summary of Posaconazole versus voriconazole for primary treatment of invasive aspergillosis: a phase 3, randomised, controlled, non-inferiority trial
Scientific Paper Plain English Summary United Kingdom
Plain English Summary – Maertens et al. (2022), Empiric vs Preemptive Antifungal Strategy in High-Risk Neutropenic Patients on Fluconazole Prophylaxis
Author:  Thomas Taynton on behalf of BioDriveAFS team
Country:  United Kingdom
Plain english summary of Empiric vs Preemptive Antifungal Strategy in High-Risk Neutropenic Patients on Fluconazole Prophylaxis: A Randomized Trial of the European Organization for Research and Treatment of Cancer
Scientific Paper Plain English Summary United Kingdom
Plain English Summary – Stemler et al. (2022) Antifungal prophylaxis in adult patients with acute myeloid leukaemia treated with novel targeted therapies
Author:  Thomas Taynton on behalf of BioDriveAFS team
Country:  United Kingdom
Plain English Summary of Antifungal prophylaxis in adult patients with acute myeloid leukaemia treated with novel targeted therapies: a systematic review and expert consensus recommendation from the European Hematology Association
Scientific Paper United Kingdom
PRO: Biomarker surveillance for invasive fungal infections
Author: 
Country:  United Kingdom
PRO: Biomarker surveillance for invasive fungal infections without antifungal prophylaxis could safely reduce antifungal use in acute leukaemia published in the Journal of of Antimicrobial Chemotherapy. Authors Thomas Taynton (Clinical Research Fellow), Gavin Barlow (Co-CI of BioDriveAFS) and David Allsup (Co-CI of BioDriveAFS)
Scientific Paper United Kingdom
Should serum biomarker monitoring replace primary antifungal chemoprophylaxis in patients with acute leukaemia receiving systemic anti-cancer therapy?
Author: 
Country:  United Kingdom
Should serum biomarker monitoring replace primary antifungal chemoprophylaxis in patients with acute leukaemia receiving systemic anti-cancer therapy? A PRO/CON debate. Published in the Journal of Antimicrobial Chemotherapy. Authors Thomas Harrison and David Partridge
fungal infection United Kingdom
Treatment of Systemic Fungal Infections
Author:  BSAC, Chaired by Gavin Barlow
Country:  United Kingdom
Webinar, 90 minutes duration
Top